A Lifelong Commitment
Cartesian was founded by physician-scientists who have dedicated their careers to treating patients and curing diseases. Leveraging mRNA Cell Therapy, Cartesian aims to develop potent, yet safe therapies with curative potential for the treatment of autoimmune diseases.
Today, as part of FDA-allowed clinical trials, we are treating patients with autoimmune diseases. We are grateful to our trial participants for partnering with us to bring these cutting-edge therapies to many more patients.
Cartesian is conducting a clinical trial in:
The below patient advocacy groups are able to provide detailed educational resources and community support to patients and families impacted with myasthenia gravis.
The Cartesian team would like to express our heartfelt thanks to patients, families, and healthcare providers who have participated in our clinical studies.